Access to Medicine Index - Methodology Report 2013 for the 2014 Access to Medicine Index
(2013; 76 pages)


As developers and manufacturers of life-saving products, the world’s leading pharmaceutical companies play an important role in improving access to medicine for the world’s poor. Through their own initiatives and in collaboration with other relevant stakeholders such as multi-lateral organisations, governments and the global health community, these companies are increasingly helping to address the access to medicine challenge.

In order to suitably capture the industry’s progress in line with society’s evolving expectations, the Access to Medicine Index methodology is systematically reviewed every two years.

While maintaining as much consistency as possible for the purpose of trend analysis, the methodology is adjusted where needed. This report describes the methodology that will be used for the 2014 Access to Medicine Index, and highlights the refinements made since the previous report.

Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019